199 related articles for article (PubMed ID: 23560535)
1. Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts.
Collins CJ; McCauliff LA; Hyun SH; Zhang Z; Paul LN; Kulkarni A; Zick K; Wirth M; Storch J; Thompson DH
Biochemistry; 2013 May; 52(19):3242-53. PubMed ID: 23560535
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2-hydroxypropyl-β-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential Niemann-Pick type C therapeutics.
Mondjinou YA; McCauliff LA; Kulkarni A; Paul L; Hyun SH; Zhang Z; Wu Z; Wirth M; Storch J; Thompson DH
Biomacromolecules; 2013 Dec; 14(12):4189-97. PubMed ID: 24180231
[TBL] [Abstract][Full Text] [Related]
3. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
Tamura A; Yui N
J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
[TBL] [Abstract][Full Text] [Related]
4. Impact of Mixed β-Cyclodextrin Ratios on Pluronic Rotaxanation Efficiency and Product Solubility.
Mondjinou YA; Hyun SH; Xiong M; Collins CJ; Thong PL; Thompson DH
ACS Appl Mater Interfaces; 2015 Nov; 7(43):23831-6. PubMed ID: 26502827
[TBL] [Abstract][Full Text] [Related]
5. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
Tamura A; Yui N
J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease.
Tamura A; Yui N
Sci Rep; 2014 Mar; 4():4356. PubMed ID: 24619155
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.
Egele K; Samaddar S; Schneider N; Thompson D; Wenz G
J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225
[TBL] [Abstract][Full Text] [Related]
9. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
[TBL] [Abstract][Full Text] [Related]
10. Structure-function relationships of cholesterol mobilization from the endo-lysosome compartment of NPC1-deficient human cells by β-CD polyrotaxanes.
Samaddar S; Bose D; Loren BP; Skulsky JL; Ilnytska O; Struzik ZJ; Storch J; Thompson DH
PLoS One; 2022; 17(12):e0268613. PubMed ID: 36584173
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and pH-triggered dethreading of alpha-cyclodextrin-poly(ethylene glycol) polyrotaxanes bearing cleavable endcaps.
Loethen S; Ooya T; Choi HS; Yui N; Thompson DH
Biomacromolecules; 2006 Sep; 7(9):2501-6. PubMed ID: 16961310
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
Wehrmann ZT; Hulett TW; Huegel KL; Vaughan KT; Wiest O; Helquist P; Goodson H
PLoS One; 2012; 7(10):e48561. PubMed ID: 23144769
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C.
Puglisi A; Yagci Y
Macromol Rapid Commun; 2019 Jan; 40(1):e1800557. PubMed ID: 30216584
[TBL] [Abstract][Full Text] [Related]
14. Tailoring the supramolecular structure of aminated polyrotaxanes toward enhanced cellular internalization.
Yokoyama N; Seo JH; Tamura A; Sasaki Y; Yui N
Macromol Biosci; 2014 Mar; 14(3):359-68. PubMed ID: 24634263
[TBL] [Abstract][Full Text] [Related]
15. Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy.
Mbua NE; Flanagan-Steet H; Johnson S; Wolfert MA; Boons GJ; Steet R
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10207-12. PubMed ID: 23733943
[TBL] [Abstract][Full Text] [Related]
16. [Intracellularly Degradable Polyrotaxanes for Therapeutic Applications].
Tamura A
Yakugaku Zasshi; 2019; 139(2):143-155. PubMed ID: 30713223
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles containing β-cyclodextrin potentially useful for the treatment of Niemann-Pick C.
Donida B; Raabe M; Tauffner B; de Farias MA; Machado AZ; Timm F; Kessler RG; Hammerschmidt TG; Reinhardt LS; Brito VB; Portugal RV; Bernardi A; Frozza R; Moura DJ; Giugliani R; Poletto F; Vargas CR
J Inherit Metab Dis; 2020 May; 43(3):586-601. PubMed ID: 31943253
[TBL] [Abstract][Full Text] [Related]
19. Analytical Characterization of Methyl-β-Cyclodextrin for Pharmacological Activity to Reduce Lysosomal Cholesterol Accumulation in Niemann-Pick Disease Type C1 Cells.
Li R; Hao J; Fujiwara H; Xu M; Yang S; Dai S; Long Y; Swaroop M; Li C; Vu M; Marugan JJ; Ory DS; Zheng W
Assay Drug Dev Technol; 2017; 15(4):154-166. PubMed ID: 28631941
[TBL] [Abstract][Full Text] [Related]
20. Sterol transfer between cyclodextrin and membranes: similar but not identical mechanism to NPC2-mediated cholesterol transfer.
McCauliff LA; Xu Z; Storch J
Biochemistry; 2011 Aug; 50(34):7341-7349. PubMed ID: 21740003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
